IP Library Granted Patent US 9,474,749
Granted Patent B2
US 9,474,749 · App. 14/460,809 · Granted Oct 25, 2016

Morphine and morphine precursors

Inventors: George B. Stefano (Melville, NY); Patrick Cadet (Elmont, NY); Kirk J. Mantione (Patchogue, NY); Wei Zhu (West Babylon, NY)
Assignee: The Research Foundation for the State University of New York
A61K31/485A23L1/30A61K31/194A61K31/198A61K31/472A61K31/7052A61K33/04A61K33/06A61K45/06A23V2002/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,474,749
App. No.
14/460,809
Granted
Oct 25, 2016
Kind
B2
Abstract

Methods and materials related to the use of morphine, morphine precursors (e.g., reticuline), and inhibitors of morphine synthesis or activity to treat diseases, to reduce inflammation, or to restore normal function are provided.

Claims (15)

1. A method for inducing nitric oxide release from cells in a mammal, said method comprising administering, to said mammal, a composition in an amount, at a frequency more frequent than once a week, and for a duration longer than one month, wherein said composition comprises thebaine, and wherein said amount of said composition results in less than 1 mg of said thebaine being administered to said mammal per kg of body weight of said mammal per day.

2. The method of claim 1 , wherein said cells are immune cells.

3. The method of claim 1 , wherein said mammal is a human.

4. The method of claim 1 , wherein said composition further comprises morphine in an amount that results in less than 0.05 mg of said morphine being administered to said mammal per kg of body weight of said mammal per day.

5. The method of claim 1 , wherein said composition is in the form of a tablet.

6. The method of claim 1 , wherein said composition comprises selenium.

7. The method of claim 1 , wherein said composition comprises L-arginine.

8. The method of claim 1 , wherein said composition comprises a calcium source.

9. The method of claim 1 , wherein said amount of said composition results in less than 0.5 mg of said thebaine being administered to said mammal per kg of body weight of said mammal per day.

10. The method of claim 1 , wherein said amount of said composition results in less than 0.05 mg of said thebaine being administered to said mammal per kg of body weight of said mammal per day.

11. The method of claim 1 , wherein said frequency is more frequent than four times a week.

12. The method of claim 1 , wherein said frequency is between two and five times a day.

13. The method of claim 1 , wherein said frequency is once a day.

14. The method of claim 1 , wherein said duration is longer than two months.

15. The method of claim 1 , wherein said duration is longer than three months.

Assignments (3)
CONFIRMATORY LICENSE Recorded Mar 20, 2018
From: STATE UNIVERSITY OF NEW YORK
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 045642/0945 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 25, 2014
From: STEFANO, GEORGE B.; CADET, PATRICK; MANTIONE, KIRK J.; ZHU, WEI
To: THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK
Reel/Frame 033601/0367 →
CHANGE OF NAME Recorded Aug 25, 2014
From: THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK
To: THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK
Reel/Frame 033606/0046 →
Continuity (6)
Continuation 13924211 · Jun 21, 2013
Continuation 12904373 · Oct 14, 2010
Continuation 11576448
Provisional Application 60714769 · Sep 6, 2005
Provisional Application 60615048 · Oct 1, 2004
Related Publication 20140348953A1 · Nov 27, 2014